Compounds > buserelin
Page last updated: 2024-08-23

buserelin and Cancer of Endometrium

buserelin has been researched along with Cancer of Endometrium in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Douvdevani, A; Kleinman, D; Levy, J; Schally, AV; Sharoni, Y1
Doi, Y; Fujimoto, S; Hamasaki, K; Kashimura, M; Sakamoto, Y1
Horibe, S; Imai, A; Takagi, A; Tamaya, T1
Karube, A; Ota, H; Sato, H; Shibata, S; Takahashi, O; Tanaka, T1
Horibe, S; Imai, A; Takagi, A; Takagi, H; Tamaya, T1

Other Studies

5 other study(ies) available for buserelin and Cancer of Endometrium

ArticleYear
Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis.
    American journal of obstetrics and gynecology, 1994, Volume: 170, Issue:1 Pt 1

    Topics: Adenocarcinoma, Papillary; Aged; Apoptosis; Buserelin; Cell Cycle; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Endometrial Neoplasms; Estradiol; Female; Flow Cytometry; Gonadotropin-Releasing Hormone; Humans; Receptors, Estrogen; Time Factors; Tumor Cells, Cultured

1994
The contraction of small arteries in the perimetrium by presurgical medication with the luteinizing hormone-releasing hormone agonist to patients with leiomyomas: an electron and immunoelectron microscopy.
    Fukuoka igaku zasshi = Hukuoka acta medica, 1995, Volume: 86, Issue:10

    Topics: Adult; Arteries; Buserelin; Endometrial Neoplasms; Endometrium; Endothelins; Endothelium, Vascular; Female; Gonadotropin-Releasing Hormone; Humans; Inclusion Bodies; Leiomyoma; Microscopy, Electron; Microscopy, Immunoelectron; Middle Aged; Premedication; Vasoconstriction

1995
Gi protein activation of gonadotropin-releasing hormone-mediated protein dephosphorylation in human endometrial carcinoma.
    American journal of obstetrics and gynecology, 1997, Volume: 176, Issue:2

    Topics: Adenosine Diphosphate Ribose; Adenosine Triphosphate; Antineoplastic Agents, Hormonal; Buserelin; Carcinoma; Endometrial Neoplasms; Enzyme Activation; Female; Gonadotropin-Releasing Hormone; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Pertussis Toxin; Phosphorylation; Receptors, LHRH; Virulence Factors, Bordetella

1997
Involvement of annexin V in antiproliferative effects of gonadotropin-releasing hormone agonists on human endometrial cancer cell line.
    Gynecologic oncology, 1997, Volume: 66, Issue:2

    Topics: Annexin A5; Antineoplastic Agents, Hormonal; Buserelin; Cell Division; Endometrial Neoplasms; Female; Humans; Receptors, LHRH; Tumor Cells, Cultured

1997
Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:2

    Topics: Apoptosis; Buserelin; Endometrial Neoplasms; fas Receptor; Female; Gene Expression; Humans; Leuprolide; Oligopeptides; Ovarian Neoplasms; Polymerase Chain Reaction; Receptors, LHRH; RNA-Directed DNA Polymerase; RNA, Messenger; Tumor Cells, Cultured

1998